These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 53769)

  • 21. [Animal experimental studies on the resorption of tramazolin eyedrops].
    von Denffer H; Dressler J; Schmahl W
    Med Monatsschr; 1977 Dec; 31(12):565-7. PubMed ID: 593220
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experience in the use of a local vasoconstrictor, Otrivin--clinical observation by double blind, cross over method and the effect on the nasal mucosa].
    Sugiura S
    Jibiinkoka; 1971 Jan; 43(1):71-86. PubMed ID: 4099381
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of different preparations of nasal decongestants on ciliary beat frequency in vitro.
    Deitmer T; Scheffler R
    Rhinology; 1993 Dec; 31(4):151-3. PubMed ID: 7511251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular effects of phenylpropanolamine on human nasal mucosa.
    Bende M; Andersson KE; Johansson CJ; Sjögren C; Svensson G
    Rhinology; 1985 Mar; 23(1):43-8. PubMed ID: 2408314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate effect of benzalkonium chloride in decongestant nasal spray on the human nasal mucosal temperature.
    Lindemann J; Leiacker R; Wiesmiller K; Rettinger G; Keck T
    Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):357-61. PubMed ID: 15270822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The tolerability of nasal drugs with special regard to preservatives and physico-chemical parameters].
    Verse T; Sikora C; Rudolph P; Klöcker N
    Laryngorhinootologie; 2003 Nov; 82(11):782-9. PubMed ID: 14634896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of decongestive capacity of xylometazoline and pseudoephedrine with rhinomanometry and MRI.
    Caenen M; Hamels K; Deron P; Clement P
    Rhinology; 2005 Sep; 43(3):205-9. PubMed ID: 16218514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of particles within the nasal airways before and after nasal decongestion.
    Keck T; Leiacker R; Kühnemann S; Rettinger G; Lindemann J
    Clin Otolaryngol Allied Sci; 2001 Aug; 26(4):324-8. PubMed ID: 11559347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal decongestion with imidazoline derivatives: acoustic rhinometry measurements.
    Hochban W; Althoff H; Ziegler A
    Eur J Clin Pharmacol; 1999 Mar; 55(1):7-12. PubMed ID: 10206078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ciliary epithelium and topical decongestants: how to minimize the undesirable events?].
    Laberko EL; Zlobina NV; Radtsig EY; Bogomil'sky MR
    Vestn Otorinolaringol; 2014; (5):76-9. PubMed ID: 25588494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of a synthetic prostaglandin and xylometazoline hydrochloride as nasal decongestants.
    Jackson RT; Birnbaum JE
    Otolaryngol Head Neck Surg; 1982; 90(5):595-7. PubMed ID: 6186975
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of pharmacologic decongestion in the generation of rhinomanometric norms for the nasal airway.
    Jessen M; Malm L
    Am J Otolaryngol; 1988; 9(6):336-40. PubMed ID: 2465702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on the pharmacologic influence on the resorption capability of the nasal mucosa in experimental animals].
    Münzel M; Naumann WH
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1970; 196(2):363-6. PubMed ID: 4099745
    [No Abstract]   [Full Text] [Related]  

  • 34. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
    Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
    Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Remarks on the physiological control of nose drops: critical study of the influence of pH; role of the buffer system].
    Grumbach PE; Kapétanidis I; Mirimanoff A; Paley A
    Pharm Acta Helv; 1965 Jul; 40(7):432-40. PubMed ID: 4160199
    [No Abstract]   [Full Text] [Related]  

  • 36. The nasal and bronchopulmonary effects of oxymetazoline and KB227.
    Carrillo L; Kishimoto T; Aviado DM
    Ann Otol Rhinol Laryngol; 1969 Apr; 78(2):415-24. PubMed ID: 4180290
    [No Abstract]   [Full Text] [Related]  

  • 37. No effect of a nasal decongestant on eustachian tube function in children with ventilation tubes.
    van Heerbeek N; Ingels KJ; Zielhuis GA
    Laryngoscope; 2002 Jun; 112(6):1115-8. PubMed ID: 12160284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment results with dioxopromethazine nose drops].
    Knothe J; Baerthold W; Aschoff E
    Pharmazie; 1970 Feb; 25(2):121-4. PubMed ID: 4192880
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of protective and therapeutic effects of dexpanthenol on nasal decongestants and preservatives: results of cytotoxic studies in vitro.
    Klöcker N; Rudolph P; Verse T
    Am J Rhinol; 2004; 18(5):315-20. PubMed ID: 15586804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inhibition of granulocyte phagocytosis by various components of nasal drops.
    Håkansson B; Linder C; Ohlsson K; Tegner H; Toremalm NG
    Pharmacol Toxicol; 1989 Aug; 65(2):89-91. PubMed ID: 2478992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.